120 related articles for article (PubMed ID: 9534199)
1. Immunohistochemical analysis of thyroid adenomas with Hurthle cells.
Kanthan R; Radhi JM
Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199
[TBL] [Abstract][Full Text] [Related]
2. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
[TBL] [Abstract][Full Text] [Related]
3. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
Judkins AR; Roberts SA; Livolsi VA
Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
[TBL] [Abstract][Full Text] [Related]
4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
5. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
[TBL] [Abstract][Full Text] [Related]
6. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
Abu-Alfa AK; Straus FH; Montag AG
Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
[TBL] [Abstract][Full Text] [Related]
9. Hidradenocarcinoma: a histological and immunohistochemical study.
Ko CJ; Cochran AJ; Eng W; Binder SW
J Cutan Pathol; 2006 Nov; 33(11):726-30. PubMed ID: 17083691
[TBL] [Abstract][Full Text] [Related]
10. Hurthle cell thyroid tumors. An immunohistochemical study.
Johnson TL; Lloyd RV; Burney RE; Thompson NW
Cancer; 1987 Jan; 59(1):107-12. PubMed ID: 3539304
[TBL] [Abstract][Full Text] [Related]
11. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
12. Solid cell nests of the thyroid. A histologic and immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Hashimoto T; Nakamura S; Ishizaki T
Am J Clin Pathol; 1994 Feb; 101(2):186-91. PubMed ID: 7509563
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component.
Stead RH; Qizilbash AH; Kontozoglou T; Daya AD; Riddell RH
Hum Pathol; 1988 Jan; 19(1):32-40. PubMed ID: 2447009
[TBL] [Abstract][Full Text] [Related]
15. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
Wong TY; Suster S; Cheek RF; Mihm MC
Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell neoplasms of the thyroid gland: an immunohistochemical study.
Chetty R
Histopathology; 1990 Oct; 17(4):368-70. PubMed ID: 2258175
[No Abstract] [Full Text] [Related]
17. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
18. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]